Stockscreener 앱 받기
1.80
62.16%
0.69
시간 외 거래:
1.68
-0.12
-6.67%
Immuron Limited Adr 주식(IMRN)의 최신 뉴스
Immuron (ASX: IMC) Pushes IMM-529 Forward with FDA Clearance and Partnering Strategy - Kalkine Media
Immuron (IMRN) Holds Gains Above $1.10 as Micro-Cap Biotech Finds Buying InterestChannel Breakout - vinanet.vn
GLIBK Q1 2026 Earnings: EPS Misses Estimates by 63.89%, Coming in at $0.45 per ShareTangible Book Value - Vinanet
Immuron Limited (IMRN) Slips 1.8% as ADR Tests Key $1.04 SupportMutual Fund Flow - vinanet.vn
Immuron (NASDAQ: IMRN) outlines FY26 growth, cash runway and CDI IND plans - Stock Titan
Immuron Limited Sponsored ADR Revenue Breakdown – MUN:ANWA - TradingView
Immuron Limited Sponsored ADR Revenue Breakdown – LSX:A2DTD8 - TradingView
Immuron Limited (NASDAQ: IMRN) highlights antibody platform at TechKnow Invest - Stock Titan
Immuron Limited (NASDAQ: IMRN) grows FY26 revenue to A$7.7m - Stock Titan
Immuron FY26 SalesFour Consecutive Quarters of Growth over Prior Year - Sahm
BNY Mellon Lifts Substantial Holding in Immuron to 44.61% via ADR Program Deposits - Kalkine
Immuron (NASDAQ: IMRN) lifts FY26 Travelan sales 6% to AUD$7.7m - Stock Titan
BNY Mellon Boosts Immuron Stake to 44.61% Through ADR Share Deposits by July 2026 - Kalkine Media
Immuron (NASDAQ: IMRN) advances IMM-529 CDI drug with new partnering push - Stock Titan
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy - GlobeNewswire Inc.
Immuron (ASX:IMC) Pursues Strategic Partnership to Advance FDA IND-Cleared IMM-529 - Kalkine Media
IMRNImmuron Limited ADR Revenue Breakdown - Finviz
A2DTD8 Forecast — Price Target — Prediction for 2027 - TradingView
ANWA Forecast — Price Target — Prediction for 2027 - TradingView
Immuron (NASDAQ: IMRN) now has 322.8M ordinary shares on issue - Stock Titan
Price to earnings forward of Immuron Limited Sponsored ADR – MUN:ANWA - TradingView
Immuron Limited Sponsored ADR Actuals & Estimates (NASDAQ:IMRN) - TradingView
Form 6K Immuron Ltd ADR For: 23 June By Investing.com - Investing.com South Africa
Form 6K Immuron Ltd ADR For: 23 June - Investing.com UK
Immuron (NASDAQ: IMRN) cancels 3.8M shares in small holder buy-back - Stock Titan
Immuron (NASDAQ: IMRN) reports expiry of 1.43M options and updated capital - Stock Titan
63MOONS.NS Q2 2026 Earnings: Revenue Surge of 351% YoY but Net Loss PersistsTrough Earnings Signal - Vinanet
ADVAIT.NS Mar 2026 Earnings: Robust Profitability Amidst Expanding OperationsEarnings Beat Streak - vinanet.vn
Immuron (ASX: IMC): Advancing Gastrointestinal Product Portfolio Across Multiple Markets - Kalkine Media
Which stocks have an unusual volume on Thursday? - ChartMill
Immuron (NASDAQ: IMRN) responds to ASX query on share price - Stock Titan
Wondering what's happening in today's after-hours session? - ChartMill
Immuron (IMRN) CCO reports 1.14M shares and 640K performance rights in Form 3 - Stock Titan
Number of shareholders of Immuron Limited Sponsored ADR – LSX:A2DTD8 - TradingView
Immuron (NASDAQ: IMRN) details TD portfolio growth and partnering push - Stock Titan
Immuron (IMRN) chairman discloses 1.67M share options - Stock Titan
Immuron (NASDAQ: IMRN) CEO schedules Emerging Growth Conference presentation - Stock Titan
Unusual VolumeStock ScreenerNews - Finviz
IMRN Stock Price, Quote & Chart | IMMURON LTD-SPON ADR (NASDAQ:IMRN) - ChartMill
Immuron Double Digit 3Q Sales Growth - Sahm
Top 10 at 11: Wall Street hits all-time highs but ASX opens lower as banks retreat - MSN
Immuron (NASDAQ: IMRN) lifts Travelan sales with strong Canada Q3 surge - Stock Titan
Immuron (NASDAQ: IMRN) offers cost-free sale facility for small shareholdings - Stock Titan
IMC:ASX AnnouncementSmall Holding Share Sale Facility13 Apr 2026 - Market Index
Operating cash flow per share of Immuron Limited Sponsored ADR – GETTEX:ANWA - TradingView
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target - Democrat and Chronicle
IMRN Earnings History & Surprises | EPS & Revenue Results | IMMURON LTD-SPON ADR (NASDAQ:IMRN) - ChartMill
Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference - Sahm
Immuron (NASDAQ: IMRN) boosts cash, pursues partners for IMM-124E and IMM-529 - Stock Titan
Immuron Reports HY26 Results and Strategic Reset - ChartMill
Immuron (NASDAQ: IMRN) gains A$1.12M non-dilutive R&D refund - Stock Titan
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target - Newport Daily News
0.86%
0.31%
자본화:
|
볼륨(24시간):